Full Schedule

6:30 AM – 7:15 AM AST

Breakfast, Exhibitors, and ePosters

Location: Grand Ballroom

Networking

6:30 AM – 1:30 PM AST

Exhibits & ePosters

Location: Grand Ballroom

Networking

6:30 AM – 2:30 PM AST

Registration

Location: Grand Ballroom Foyer

7:15 AM – 7:30 AM AST

Welcome

Location: Miramar I & II

Chair: – Stony Brook University Hospital

7:30 AM – 8:30 AM AST

HPB Abstract Session

Location: Miramar I & II

Moderator: – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA

Moderator: – Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Johns Hopkins Hospital

HPBCME

7:30 AM – 7:40 AM AST

25: Navigating Complications and Functional Lifespan: A Single-Center's Review of Hepatic Artery Infusion Pumps

Location: Miramar I & II

Abstract Presenter: – University of Colorado Anschutz Medical Campus

Submitter: – University of Colorado Anschutz Medical Campus

Author: – University of Colorado Anschutz Medical Campus

Author: – University of Colorado

Author: – University of Colorado Anschutz Medical Campus

Author: – University of Colorado, Department of Surgery

Author: – University of Colorado Anschutz Medical Campus

Author: – University of Colorado, Department of Surgery

Author: – University of Colorado

HPB

7:40 AM – 7:50 AM AST

26: A Prospective Evaluation of a Modified Hepatic Arterial Infusion Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases

Location: Miramar I & II

Abstract Presenter: – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Submitter: – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – OHSU, Department of Pharmacy Services, Portland, OR 97239 USA

Author: – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA

Author: – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA

HPB

7:50 AM – 8:00 AM AST

27: Initial Outcomes of a Single-Institution Hepatic Artery Infusion Pump Program for Colorectal Liver Metastases and Intrahepatic Cholangiocarcinoma

Location: Miramar I & II

Abstract Presenter: – Case Western Reserve University School of Medicine

Submitter: – Case Western Reserve University School of Medicine

Author: – Case Western Reserve University School of Medicine

Author: – University Hospitals

Author: – Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

HPB

8:00 AM – 8:10 AM AST

28: Perioperative and oncologic outcomes of hepatic arterial infusion pump chemotherapy for patients with unresectable colorectal liver metastases at an expanding HAI program

Location: Miramar I & II

Abstract Presenter: – Duke University Medical Center

Submitter: – Duke University Medical Center

Author: – Duke University Medical Center

Author: – Duke Cancer Institute

Author: – Duke Univeristy School of Medicine

Author: – Duke University School of Medicine

Author: – Duke University Medical Center

Author: – The Oregon Clinic

Author: – Fred Hutchinson Cancer Center, University of Washington Medical Center

Author: – Duke University School of Medicine

Author: – Duke Cancer Institute

Author: – Duke University School of Medicine

Author: – Duke University Medical Center

Author: – Duke University School of Medicine

Author: – Duke University Medical Center

HPB

8:10 AM – 8:20 AM AST

29: The Association of Pre-Hepatic Artery Infusion Pump Systemic Chemotherapy with Intrahepatic Floxuridine Tolerance

Location: Miramar I & II

Abstract Presenter: – University of Kentucky College of Medicine Department of Surgery

Submitter: – University of Kentucky College of Medicine Department of Surgery

Author: – University of Kentucky College of Medicine Department of Surgery

Author: – University of Kentucky College of Pharmacy

Author: – University of Kentucky College of Medicine Department of Surgery

Author: – Division of Surgical Oncology, Department of Surgery, University of Kentucky

Author: – Department of Internal Medicine, University of Kentucky

Author: – Division of Surgical Oncology, Department of Surgery, University of Kentucky

HPB

8:30 AM – 9:30 AM AST

Management of Synchronous Rectal Cancer Liver Metastases

Location: Miramar I & II

Moderator: – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Moderator: – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA

HPBCME

8:30 AM – 8:45 AM AST

Combined versus Staged Resection – Who, When, and Why

Location: Miramar I & II

Presenter: – Mayo Clinic

8:45 AM – 9:00 AM AST

Liver Resection in the Era of TNT and Non-operative Management of the Rectal Primary

Location: Miramar I & II

Presenter: – The University of Texas MD Anderson Cancer Center

9:00 AM – 9:15 AM AST

What to do with the Primary Tumor in Patients with Unresectable Liver Metastases Treated with HAI

Location: Miramar I & II

Presenter: – Memorial Sloan Kettering Cancer Center

9:15 AM – 9:30 AM AST

Questions & Answers

Location: Miramar I & II

9:30 AM – 9:45 AM AST

Refreshments/Exhibitor Break

Location: Grand Ballroom

Networking

9:45 AM – 10:45 AM AST

PSM Abstract Session 1

Location: Miramar I & II

Moderator: – Oregon Health & Science University

Moderator: – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA

PSMCME

9:45 AM – 9:55 AM AST

1: Outcomes and Surveillance After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Uterine Leiomyosarcoma

Location: Miramar I & II

Abstract Presenter: – Stanford University School of Medicine

Submitter: – Stanford University School of Medicine

Author: – Stanford University School of Medicine

Gynecologic Oncology

9:55 AM – 10:05 AM AST

12: The Landscape of Circulating Tumor DNA (ctDNA) in Appendiceal Adenocarcinoma (AA)

Location: Miramar I & II

Abstract Presenter: – Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Submitter: – Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Author: – Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Author: – Cleveland Clinic Akron General Hospital

Author: – University of Texas MD Anderson Cancer Center

Author: – The University of Texas MD Anderson Cancer Center

Author: – Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Author: – The University of Texas MD Anderson Cancer Center

Author: – Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Author: – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Author: – The University of Texas MD Anderson Cancer Center

Author: – Division of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, United States

Author: – Guardant Health

Author: – The University of Texas MD Anderson Cancer Center

PSM

10:05 AM – 10:15 AM AST

20: GNAS Driver Mutations in Primary and Metastatic Nonmucinous Appendiceal Adenocarcinoma Versus Analogous Colorectal Cancers. An AACR Project GENIE Analysis.

Location: Miramar I & II

Abstract Presenter: – Department of Surgery, University of Tennessee Health Science Center

Submitter: – Department of Surgery, University of Tennessee Health Science Center

Author: – Department of Surgery, University of Tennessee Health Science Center

Author: – Moffitt Cancer Center

Author: – Department of Surgery, The University of Tennessee Health Science Center

Author: – Department of Biostatistics, St. Jude Children’s Research Hospital

Author: – Department of Surgery, The University of Tennessee Health Science Center

Author: – Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA

Author: – Department of Surgery, St. Jude Children’s Research Hospital

Author: – Department of Surgery, University of North Carolina

Author: – Department of Surgery, University of Tennessee Health Science Center

Author: – University of Tennessee Health Science Center, Department of Surgery

Author: – University of North Carolina at Chapel Hill

PSM

10:15 AM – 10:25 AM AST

4: Who Benefits from Specialist Palliative Care among Patients Undergoing Major Abdominal Surgery for Cancer?: Subgroup Analysis of the Surgery for Cancer with Option of Palliative Expert (SCOPE) Trial

Location: Miramar I & II

Abstract Presenter: – Moffitt Cancer Center

Submitter: – Moffitt Cancer Center

Author: – Moffitt Cancer Center

Author: – Vanderbilt University Medical Center

Author: – Vanderbilt Department of Surgery

PSM

10:25 AM – 10:35 AM AST

8: Decision Regret in Appendiceal Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Location: Miramar I & II

Abstract Presenter: – University of New Mexico Comprehensive Cancer Center

Author: – University of New Mexico

Author: – University of Utah

Author: – University of New Mexico Comprehensive Cancer Center

Author: – University of New Mexico Health Sciences Center

Author: – Oregon Health & Science University

Author: – University of New Mexico Comprehensive Cancer Center

Submitter: – University of New Mexico Comprehensive Cancer Center

Author: – University of New Mexico Comprehensive Cancer Center

PSM

10:35 AM – 10:45 AM AST

10: Efficacy and safety of PD-L1 (atezolizumab) and VEGF (bevacizumab) inhibition in metastatic appendiceal adenocarcinoma

Location: Miramar I & II

Author: – The University of Texas MD Anderson Cancer Center

Author: – Cleveland Clinic Akron General Hospital

Author: – University of Texas MD Anderson Cancer Center

Author: – The University of Texas MD Anderson Cancer Center

Author: – University of Texas MD Anderson Cancer Center

Author: – Georgia Tech

Author: – The University of Texas MD Anderson Cancer Center

Author: – Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston TX, USA

Author: – University of Texas MD Anderson Cancer Center

Author: – The University of Texas MD Anderson Cancer Center

Abstract Presenter: – The University of Texas MD Anderson Cancer Center

Submitter: – The University of Texas MD Anderson Cancer Center

Author: – The University of Texas MD Anderson Cancer Center

PSM

10:45 AM – 11:30 AM AST

Saturday Poster Presentations

Location: Miramar I & II

Poster Session Moderator: – Penn State College of Medicine

Poster Session Moderator: – University of Pittsburgh Medical Center

PostersCME

10:45 AM – 10:50 AM AST

P10: Small Bowel Obstruction and Ovarian Cancer: Insights from a Propensity-Score Matched Study in Patients with and without Hyperthermic Intraperitoneal Chemotherapy after Cytoreductive Surgery

Location: Miramar I & II

Oral Poster Presenter: – Mercy Medical Center

Author: – Mercy Medical Center

Submitter: – The Institute for Cancer Care, Mercy Medical Center

Author: – The Institute for Cancer Care, Mercy Medical Center

Author: – Mercy Medical Center

Author: – The Lya Segall Ovarian Cancer Institute, Mercy Medical Center

Author: – Mercy Medical Center

Gynecologic Oncology

10:50 AM – 10:55 AM AST

P14: Treatment Outcomes of Incidental Gallbladder Cancer – results from a high-volume tertiary care centre in North India

Location: Miramar I & II

Oral Poster Presenter: – KING GEORGE'S MEDICAL UNIVERSITY

Submitter: – KING GEORGE'S MEDICAL UNIVERSITY

Author: – KING GEORGE'S MEDICAL UNIVERSITY

Author: – KING GEORGE'S MEDICAL UNIVSERSITY

Author: – KING GEORGE'S MEDICAL UNIVERSITY

Author: – KING GEORGE'S MEDICAL UNIVSERSITY

Author: – ATAL BIHARI VAJPAYEE MEDICAL UNIVERSITY

HPB

10:55 AM – 11:00 AM AST

P16: Prospective Evaluation of the Safety and Quality of Life in Patients Receiving Hepatic Artery Infusion Pump Chemotherapy

Location: Miramar I & II

Oral Poster Presenter: – Mayo Clinic

Submitter: – Mayo Clinic

Author: – Mayo Clinic

Author: – Mayo Clinic, Rochester, MN, United States

Author: – Mayo Clinic

HPB

11:00 AM – 11:05 AM AST

P15: Outcomes of hepatic artery-based therapies and systemic multiagent chemotherapy in unresectable colorectal liver metastases: A systematic review and meta-analysis

Location: Miramar I & II

Oral Poster Presenter: – Department of Surgery, Tulane University School of Medicine

Submitter: – Department of Surgery, Tulane University School of Medicine

Author: – Department of Surgery, Tulane University School of Medicine

Author: – 2. Case Western Reserve University School of Medicine, Cleveland, OH

Author: – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – Department of Medicine, Division of Hematology/Oncology, University Hospitals Seidman Cancer Center, case Western Reserve University, Cleveland, OH

Author: – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

Author: – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH

HPB

11:05 AM – 11:10 AM AST

P13: Pre-operative biomarkers may predict nodal status in pancreas adenocarcinoma

Location: Miramar I & II

Oral Poster Presenter: – University of Utah Hospital

Submitter: – University of Utah Hospital

Author: – University of Utah Hospital

Author: – University of Utah, Department of Surgery

Author: – Huntsman Cancer Institute

HPB

11:10 AM – 11:15 AM AST

P3: Abdominal wall reconstruction with biological mesh is a durable and safe technique in patients undergoing cytoreductive surgery

Location: Miramar I & II

Oral Poster Presenter: – University of Colorado

Author: – University of Colroado

Author: – University of Colorado, Department of Surgery

Author: – University of Colorado

Author: – University of Colorado Anschutz Medical Campus

PSM

11:15 AM – 11:20 AM AST

P4: Integrated Characterization of Cell types, States, and Molecular Programs in Disseminated Appendiceal Neoplasms

Location: Miramar I & II

Oral Poster Presenter: – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA

Author: – Translational Genomics

Author: – City of Hope Cancer Center

Author: – Department of Pathology, City of Hope National Medical Center

Author: – City of Hope Cancer Center

Author: – Vanderbilt University Medical Center

Author: – Translational Genomics

Submitter: – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA

Author: – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA

PSM

11:20 AM – 11:25 AM AST

P1: Feasibility, Safety and Efficacy of a Systemic Opioid-Free Postoperative Pain Management Pathway in Cytoreductive Surgery

Location: Miramar I & II

Oral Poster Presenter: – Department of Surgery, CHU Moises Broggi

Author: – Clinica Vida Fundación

Author: – Peritoneal Surface Malignancies Unit, Department of Surgery, CHU Moises Broggi

Author: – Department of General Surgery, CHU Moises Broggi

Author: – Peritoneal Surface Malignancies Unit, Department of Surgery, CHU Moises Broggi

Author: – Peritoneal Surface Malignancies Unit, department of Surgery, CHU Moises Broggi

PSM

11:30 AM – 12:00 PM AST

Chair Lecture

Location: Miramar I & II

Chair: – Stony Brook University Hospital

non-CME

12:00 PM – 12:30 PM AST

Lunch & Visit Exhibitors

Location: Grand Ballroom

Networking

12:30 PM – 1:30 PM AST

PSM Abstract Session 2

Location: Miramar I & II

Moderator: – Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, USA

PSMCME

12:30 PM – 12:40 PM AST

14: Effect of Travel Distance on Outcomes of Patients with Malignant Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Location: Miramar I & II

Author: – University of New Mexico

Author: – University of New Mexico Health Sciences Center

Abstract Presenter: – University of New Mexico Comprehensive Cancer Center

Submitter: – University of New Mexico Comprehensive Cancer Center

Author: – University of New Mexico Comprehensive Cancer Center

PSM

12:40 PM – 12:50 PM AST

15: Beyond Standard Measures: A Comprehensive Evaluation of Quality of Life in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Survivors

Location: Miramar I & II

Abstract Presenter: – Mercy Medical Center

Author: – Mercy Medical Center

Author: – The Institute for Cancer Care, Mercy Medical Center

Author: – Mercy Medical Center

Submitter: – The Institute for Cancer Care, Mercy Medical Center

Author: – The Institute for Cancer Care, Mercy Medical Center

PSM

12:50 PM – 1:00 PM AST

21: High Volume Teams of Surgeons and Anesthesiologists are Associated with Lower Operating Room Cost of CRS-HIPEC

Location: Miramar I & II

Abstract Presenter: – Johns Hopkins University School of Medicine

Submitter: – Johns Hopkins University School of Medicine

Author: – Johns Hopkins University School of Medicine

Author: – Division of Gastrointestinal Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States

Author: – Johns Hopkins University School of Medicine

PSM

1:00 PM – 1:10 PM AST

23: Socioeconomic Status and Outcomes in Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy (CRS and HIPEC)

Location: Miramar I & II

Abstract Presenter: – UPMC

Submitter: – UPMC

Author: – UPMC

Author: – University of Colroado

Author: – AHN

Author: – UPMC

Author: – University of Pittsburgh Medical Center

PSM

1:10 PM – 1:20 PM AST

6: Predicting Severe Postoperative Complications After CRS-HIPEC: An Externally Validated Machine Learning Tool

Location: Miramar I & II

Abstract Presenter: – University of California San Francisco

Author: – University of California, San Francisco

Author: – AHN

Author: – Department of Surgery, University of California San Francisco

Author: – University of California, Berkeley

Author: – University of California, San Francisco

Author: – Surgical Director of UW Health Liver and Pancreas Center

Author: – University of Wisconsin School of Medical and Public Health

Author: – MD Anderson Cancer Center

Author: – Division of Surgical Oncology, Emory University, Atlanta, GA, United States

Author: – Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, United States

Author: – Division of Surgical Oncology, City of Hope National Medical Center, Duarte, CA

Author: – Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, United States

Author: – UPMC

PSM

1:20 PM – 1:30 PM AST

7: Understanding Curability and Life Expectancy – An Analysis of Patient Factors that Affect Views on Cancer Prognosis and Concordance with their Surgeon

Location: Miramar I & II

Abstract Presenter: – Stanford University School of Medicine

Submitter: – Stanford University School of Medicine

Author: – Stanford University School of Medicine

PSM

1:35 PM – 3:05 PM AST

Career Development Workshop: Developing Peritoneal Surface Malignancy and Regional Therapies Programs - Panel Session

Location: Laguna I

Moderator: – Stony Brook University Hospital

Moderator: – University of California, Irvine

Panelist: – Yale University

Panelist: – Texas Oncology Sugical Specialist

Panelist: – Vanderbilt University Medical Center

non-CME

1:35 PM – 3:05 PM AST

HPB Workshop: Liver Augmentation Strategies

Location: Miramar I & II

Moderator: – Mayo Clinic

Moderator: – Duke University Medical Center

HPBnon-CME

1:40 PM – 1:55 PM AST

Portal Vein Embolization and the Role of Total Venous Deprivation

Location: Miramar I & II

Workshop Presenter: – Memorial Sloan Kettering Cancer Center

1:55 PM – 2:10 PM AST

Radioembolization as a Liver Augmentation Strategy

Location: Miramar I & II

Workshop Presenter: – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA

2:10 PM – 2:25 PM AST

ALPPS – is it really worth it?

Location: Miramar I & II

Workshop Presenter: – Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Johns Hopkins Hospital

2:25 PM – 2:40 PM AST

Assessment of the Future Liver Remnant – Beyond Volumetrics

Location: Miramar I & II

Workshop Presenter: – Oregon Health & Science University

2:40 PM – 3:05 PM AST

HPB Workshop: Panel Discussion

Location: Miramar I & II

Panelist: – Memorial Sloan Kettering Cancer Center

Panelist: – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA

Panelist: – Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Johns Hopkins Hospital

Panelist: – Oregon Health & Science University